000 01556 a2200469 4500
005 20250515092546.0
264 0 _c20080129
008 200801s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.23097
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTavernier, Emmanuelle
245 0 0 _aSecondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
_h[electronic resource]
260 _bCancer
_cDec 2007
300 _a2747-55 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms, Second Primary
_xepidemiology
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aPrognosis
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aSurvival Analysis
700 1 _aLe, Quoc-Hung
700 1 _ade Botton, Stéphane
700 1 _aDhédin, Nathalie
700 1 _aBulabois, Claude-Eric
700 1 _aReman, Oumedaly
700 1 _aVey, Norbert
700 1 _aLhéritier, Véronique
700 1 _aDombret, Hervé
700 1 _aThomas, Xavier
773 0 _tCancer
_gvol. 110
_gno. 12
_gp. 2747-55
856 4 0 _uhttps://doi.org/10.1002/cncr.23097
_zAvailable from publisher's website
999 _c17482437
_d17482437